Cargando…
Combining antiviral drugs with BET inhibitors is beneficial in combatting SARS‐CoV‐2 infection
The COVID‐19 pandemic caused by the novel coronavirus SARS‐CoV‐2 has resulted in more than 500 million cases and 6 million deaths. Several antiviral therapies and vaccines have been developed to mitigate the spread of this infection. However, new approaches are required to battle emerging SARS‐CoV‐2...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9137278/ https://www.ncbi.nlm.nih.gov/pubmed/35633739 http://dx.doi.org/10.1002/ctd2.66 |